Your browser doesn't support javascript.
loading
Latent Profile Analysis of Neuropsychiatric Symptoms and Cognitive Function of Adults 2 Weeks After Traumatic Brain Injury: Findings From the TRACK-TBI Study.
Brett, Benjamin L; Kramer, Mark D; Whyte, John; McCrea, Michael A; Stein, Murray B; Giacino, Joseph T; Sherer, Mark; Markowitz, Amy J; Manley, Geoffrey T; Nelson, Lindsay D; Adeoye, Opeolu; Badjatia, Neeraj; Boase, Kim; Barber, Jason; Bodien, Yelena; Bullock, M Ross; Chesnut, Randall; Corrigan, John D; Crawford, Karen; Diaz-Arrastia, Ramon; Dikmen, Sureyya; Duhaime, Ann-Christine; Ellenbogen, Richard; Feeser, V Ramana; Ferguson, Adam R; Foreman, Brandon; Gardner, Raquel; Gaudette, Etienne; Gonzalez, Luis; Gopinath, Shankar; Gullapalli, Rao; Hemphill, J Claude; Hotz, Gillian; Jain, Sonia; Keene, C Dirk; Korley, Frederick K; Kramer, Joel; Kreitzer, Natalie; Levin, Harvey; Lindsell, Chris; Machamer, Joan; Madden, Christopher; Martin, Alastair; McAllister, Thomas; Merchant, Randall; Mukherjee, Pratik; Ngwenya, Laura B; Noel, Florence; Okonkwo, David; Palacios, Eva.
Afiliación
  • Brett BL; Department of Neurosurgery, Medical College of Wisconsin, Milwaukee.
  • Kramer MD; Department of Neurology, Medical College of Wisconsin, Milwaukee.
  • Whyte J; Independent consultant.
  • McCrea MA; Moss Rehabilitation Research Institute, Elkins Park, Pennsylvania.
  • Stein MB; Department of Neurosurgery, Medical College of Wisconsin, Milwaukee.
  • Giacino JT; Department of Neurology, Medical College of Wisconsin, Milwaukee.
  • Sherer M; Department of Psychiatry, University of California, San Diego, La Jolla.
  • Markowitz AJ; Department of Family Medicine and Public Health, University of California, San Diego, La Jolla.
  • Manley GT; VA San Diego Healthcare System, San Diego, California.
  • Nelson LD; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts.
  • Adeoye O; TIRR Memorial Hermann, Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, Texas.
  • Badjatia N; Department of Neurological Surgery, University of California, San Francisco, San Francisco.
  • Boase K; Department of Neurological Surgery, University of California, San Francisco, San Francisco.
  • Barber J; Department of Neurosurgery, Medical College of Wisconsin, Milwaukee.
  • Bodien Y; Department of Neurology, Medical College of Wisconsin, Milwaukee.
  • Chesnut R; University of Cincinnati, Cincinnati, Ohio.
  • Corrigan JD; University of Maryland, College Park.
  • Crawford K; University of Washington, Seattle.
  • Diaz-Arrastia R; University of Washington, Seattle.
  • Dikmen S; Massachusetts General Hospital, Boston.
  • Duhaime AC; University of Miami, Florida.
  • Ellenbogen R; University of Washington, Seattle.
  • Feeser VR; Ohio State University, Columbus.
  • Ferguson AR; University of Southern California, Los Angeles.
  • Foreman B; University of Pennsylvania, Philadelphia.
  • Gardner R; University of Washington, Seattle.
  • Gaudette E; MassGeneral Hospital for Children, Boston, Massachusetts.
  • Gonzalez L; University of Washington, Seattle.
  • Gopinath S; Virginia Commonwealth University, Richmond.
  • Gullapalli R; University of California, San Francisco.
  • Hemphill JC; University of Cincinnati, Cincinnati, Ohio.
  • Hotz G; University of California, San Francisco.
  • Jain S; University of Southern California, Los Angeles.
  • Keene CD; TIRR Memorial Hermann, Houston, Texas.
  • Korley FK; Baylor College of Medicine, Houston, Texas.
  • Kramer J; University of Maryland, College Park.
  • Kreitzer N; University of California, San Francisco.
  • Levin H; University of Miami, Florida.
  • Lindsell C; University of California, San Diego.
  • Machamer J; University of Washington, Seattle.
  • Madden C; University of Michigan, Ann Arbor.
  • Martin A; University of California, San Francisco.
  • McAllister T; University of Cincinnati, Cincinnati, Ohio.
  • Merchant R; Baylor College of Medicine, Houston, Texas.
  • Mukherjee P; Vanderbilt University, Nashville, Tennessee.
  • Ngwenya LB; University of Washington, Seattle.
  • Noel F; UT Southwestern Medical Center, Dallas, Texas.
  • Okonkwo D; University of California, San Francisco.
  • Palacios E; Indiana University, Bloomington.
JAMA Netw Open ; 4(3): e213467, 2021 03 01.
Article en En | MEDLINE | ID: mdl-33783518
Importance: Heterogeneity across patients with traumatic brain injury (TBI) presents challenges for clinical care and intervention design. Identifying distinct clinical phenotypes of TBI soon after injury may inform patient selection for precision medicine clinical trials. Objective: To investigate whether distinct neurobehavioral phenotypes can be identified 2 weeks after TBI and to characterize the degree to which early neurobehavioral phenotypes are associated with 6-month outcomes. Design, Setting, and Participants: This prospective cohort study included patients presenting to 18 US level 1 trauma centers within 24 hours of TBI from 2014 to 2019 as part of the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. Data were analyzed from January 28, 2020, to January 11, 2021. Exposures: TBI. Main Outcomes and Measures: Latent profiles (LPs) were derived from common dimensions of neurobehavioral functioning at 2 weeks after injury, assessed through National Institutes of Health TBI Common Data Elements (ie, Brief Symptom Inventory-18, Patient Health Questionnaire-9 Depression checklist, Posttraumatic Stress Disorder Checklist for DSM-5, PROMIS Pain Intensity scale, Insomnia Severity Index, Rey Auditory Verbal Learning Test, Wechsler Adult Intelligence Scale-Fourth Edition Coding and Symbol Search subtests, Trail Making Test, and NIH Toolbox Cognitive Battery Pattern Comparison Processing Speed, Dimensional Change Card Sort, Flanker Inhibitory Control and Attention, and Picture Sequence Memory subtests). Six-month outcomes were the Satisfaction With Life Scale (SWLS), Quality of Life after Brain Injury-Overall Scale (QOLIBRI-OS), Glasgow Outcome Scale-Extended (GOSE), and Rivermead Post-Concussion Symptoms Questionnaire (RPQ). Results: Among 1757 patients with TBI included, 1184 (67.4%) were men, and the mean (SD) age was 39.9 (17.0) years. LP analysis revealed 4 distinct neurobehavioral phenotypes at 2 weeks after injury: emotionally resilient (419 individuals [23.8%]), cognitively impaired (368 individuals [20.9%]), cognitively resilient (620 individuals [35.3%]), and neuropsychiatrically distressed (with cognitive weaknesses; 350 individuals [19.9%]). Adding LP group to models including demographic characteristics, medical history, Glasgow Coma Scale score, and other injury characteristics was associated with significantly improved estimation of association with 6-month outcome (GOSE R2 increase = 0.09-0.19; SWLS R2 increase = 0.12-0.22; QOLIBRI-OS R2 increase = 0.14-0.32; RPQ R2 = 0.13-0.34). Conclusions and Relevance: In this cohort study of patients with TBI presenting to US level-1 trauma centers, qualitatively distinct profiles of symptoms and cognitive functioning were identified at 2 weeks after TBI. These distinct phenotypes may help optimize clinical decision-making regarding prognosis, as well as selection and stratification for randomized clinical trials.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Cognición / Lesiones Traumáticas del Encéfalo Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Netw Open Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Cognición / Lesiones Traumáticas del Encéfalo Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Netw Open Año: 2021 Tipo del documento: Article